Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
135 participants
INTERVENTIONAL
2018-03-16
2024-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Interoceptive Mechanisms of Body Image Disturbance in Anorexia Nervosa
NCT06332963
Effects of Reduced Environmental Stimulation on Eating Disorders
NCT02801084
Effectiveness of a Dissonance-Based Eating Disorder Prevention Program (The Body Project II)
NCT00663754
The Body Project: Comparing the Effectiveness of an In-person and Virtually Delivered Intervention.
NCT05794763
Virtual Body Project Groups Led by Peers Versus Clinicians
NCT05993728
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Body image disturbance can be conceptualized as having two main components: perceptual, and attitudinal/affective. These might be considered two distinct constructs, best measured independently. However, clinicians currently rely upon self-report questionnaires that evaluate aggregates of symptoms, perceptual experiences, behaviors, and thoughts linked to the disorder. Some scales selectively evaluate body image characteristics such as body dissatisfaction and body distortion. However, it is unclear to what degree each of these measures quantifies the specific components of perceptual experiences vs. attitudinal/affective aspects. This study aims to evaluate whether a new electronic instrument, here referred to as the 'Body App', which separates estimations of body shape and size from the attitudinal/affective component might result in closer approximations of the perceptual component of weight or shape disturbance, and facilitate the assessment of body image disturbance in eating disorders.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Eating disorder
Measurement of body image via Body App and relationship to body measurement
Body App
Participants will indicate areas of concern on a virtual manikin using an electronic online interface. Body measurements will also be collected.
Healthy comparison
Measurement of body image via Body App and relationship to body measurement
Body App
Participants will indicate areas of concern on a virtual manikin using an electronic online interface. Body measurements will also be collected.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Body App
Participants will indicate areas of concern on a virtual manikin using an electronic online interface. Body measurements will also be collected.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Receiving inpatient treatment for eating disorder
* Body mass index greater than or equal to 14
* Independently ambulatory
* Possession of a smartphone with data plan
* English proficiency
* No current psychiatric diagnosis
* Body mass index greater than or equal to 14
* Independently ambulatory
* Possession of a smartphone with data plan
* English proficiency
Exclusion Criteria
* Comorbid schizophrenia spectrum or other psychotic disorder.
Healthy comparison group:
* Body mass index \> 41
* Active suicidal ideation
13 Years
64 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Laureate Institute for Brain Research, Inc.
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sahib Khalsa, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Laureate Institute for Brain Research
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Laureate Institute for Brain Research
Tulsa, Oklahoma, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-001-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.